News Press Releases

22 Stocks Moving In Tuesday's Pre-Market Session

X, FOXF, BGS, ARRY, ACAD, NCLH, EGRX | August 9, 2016

Gainers

Health Insurance Innovations Inc (NASDAQ: HIIQ) rose 40.3 percent to $5.61 in pre-market trading after the company posted upbeat quarterly results and raised its FY16 guidance.
Endo International plc (NASDAQ: ENDP) shares rose 12 percent to $20.38 in pre-market trading as the company announced stronger-than-expected results for the second quarter.
Castlight Health Inc (NYSE: CSLT) rose 9.4 percent to $3.71 in pre-market trading. Castlight Health reported a Q2 loss of $0.17 per share on revenue of $23.58 million.
Nevro Corp (NYSE: NVRO) shares rose 8.1 percent to $87.50 in pre-market trading after the company reported better-than-expected Q2 results and updated its FY 16 guidance.
Kandi Technologies Group Inc (NASDAQ: KNDI) shares rose 7.1 percent to $8.30 in pre-market trading. Kandi Technologies reported Q2 earnings of $0.06 per share on revenue of $55.2 million.
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) rose 5.4 percent to $27.74 in pre-market trading as the company announced better-than-expected earnings for the latest quarter.
Opko Health Inc. (NASDAQ: OPK) rose 4.2 percent to $10.53 in the pre-market trading session. OPKO Health reported quarterly earnings of $0.02 per share on revenue of $357 million.
Eagle Pharmaceuticals Inc (NASDAQ: EGRX) shares rose 3.9 percent to $50.25 in pre-market trading. Eagle Pharma posted Q2 earnings of $0.84 per share on revenue of $40.9 million and reported positive outcome from the FDA meeting for Ryanodex for exertional heat stroke NDA submission.
Zeltiq Aesthetics Inc (NASDAQ: ZLTQ) rose 3.3 percent to $35.00 in pre-market trading. ZELTIQ reported a Q2 loss of $0.12 per share on revenue of $89.46 million.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

TubeMogul Inc (NASDAQ: TUBE) shares fell 22.9 percent to $9.75 in pre-market trading after the company reported a wider-than-expected quarterly loss.
Array Biopharma Inc (NASDAQ: ARRY) shares declined 10.1 percent to $4.00 in the pre-market trading session. AstraZeneca reported that its Phase III trial of selumetinib in non-small cell lung cancer did not meet primary endpoint. Array BioPharma was informed of these results on Monday, August 8, 2016.
Manitowoc Company Inc (NYSE: MTW) shares fell 9.3 percent to $5.25 in pre-market trading after the company posted downbeat quarterly revenue.
IAMGOLD Corp (USA) (NYSE: IAG) shares fell 8.5 percent to $5.20 in pre-market trading as the company reported a bought deal financing of up to $230 million.
Norwegian Cruise Line Holdings Ltd (NASDAQ: NCLH) dropped 8.2 percent to $39.44 in pre-market trading. Norwegian Cruise Line posted downbeat quarterly revenue and issued a weak earnings forecast.
Fox Factory Holding Corp (NASDAQ: FOXF) fell 8.1 percent to $18.50 in pre-market trading. Fox Factory reported a secondary public offering of 3.5 million shares.
NeoPhotonics Corp (NYSE: NPTN) shares dropped 7.8 percent to $12.35 in pre-market trading as the company posted downbeat Q2 revenue and issued a weak forecast for the current quarter.
VTTI Energy Partners LP (NYSE: VTTI) fell 7 percent to $19.26 in pre-market trading. VTTI Energy priced a 5.25 million share offering at $19.30 per share. VTTI Energy reported a Q2 a loss of $3.4 million.
Gap Inc (NYSE: GPS) shares fell 4.5 percent to $24.48 in pre-market trading. Gap reported a 4 percent drop in its July same-store sales. The company projects Q2 adjusted earnings of $0.58 to $0.59 per share.
United States Steel Corporation (NYSE: X) shares fell 3.8 percent to $24.85 in pre-market trading. United States Steel reported a proposed common stock offering of 17 million shares.
B&G Foods, Inc. (NYSE: BGS) fell 3.8 percent to $49.15 in pre-market trading. B&G Foods announced a public offering of 3.75 million shares of common stock.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) shares fell 3.6 percent to $95.49 in pre-market trading. BioMarin reported a public offering of 7.5 million shares of common stock.
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares fell 3.2 percent to $34.10 in pre-market trading. ACADIA Pharmaceuticals reported a proposed public offering of common stock of $200 million.